person · Reporting owner

Dorer Benno O

Disclosed activity across 4 companies

Tapewire entity: 74720
SEC CIK: 0001456667

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CLOROX CO /DE/CLX · Entity 3474	Director · Executive Chair	November 30, 2020	December 02, 2020
GENERAL MILLS INCGIS · Entity 3236	Director	September 29, 2026	October 01, 2026
Origin Materials, Inc.ORGN · Entity 52695	Director	August 15, 2022	August 17, 2022
V F CORPVFC · Entity 3887	Director	May 28, 2024	May 31, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CLOROX CO /DE/

Report date November 30, 2020 · Filed December 02, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	170,689	Ending reported balance After 2020-11-30 transaction · row 7 7 source rows · reconciled sequence Row 1 · 2020-11-30 · Exercise / conversion · Acquired 172,850 · Balance 293,341 Row 2 · 2020-11-30 · Exercise / conversion · Acquired 165,400 · Balance 458,741 Row 3 · 2020-11-30 · Exercise / conversion · Acquired 128,970 · Balance 587,711 Row 4 · 2020-11-30 · Sale · Disposed 1,531 · Balance 586,180 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F2: This transaction was executed in multiple trades at prices ranging from $203.0000 to $203.1200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2020-11-30 · Sale · Disposed 22,566 · Balance 563,614 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F3: This transaction was executed in multiple trades at prices ranging from $202.0000 to $202.9600. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 6 · 2020-11-30 · Sale · Disposed 163,250 · Balance 400,364 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F4: This transaction was executed in multiple trades at prices ranging from $201.0000 to $201.9900. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 7 · 2020-11-30 · Sale · Disposed 229,675 · Balance 170,689 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F5: This transaction was executed in multiple trades at prices ranging from $200.0000 to $200.9950. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $135.57 · Expires 2027-09-12	Direct	42,990	Reported balance After 2020-11-30 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2020-11-30 · Exercise / conversion · Disposed 128,970 · Balance 42,990 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $123.09 · Expires 2026-09-13	Direct	0	Reported balance After 2020-11-30 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2020-11-30 · Exercise / conversion · Disposed 172,850 · Balance 0 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $111.60 · Expires 2025-09-15	Direct	0	Reported balance After 2020-11-30 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2020-11-30 · Exercise / conversion · Disposed 165,400 · Balance 0 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.
Common StockSEC Table I · non-derivative	IndirectAs UTMA custodian for son	8	Reported balance Holding disclosure · report date 2020-11-30 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 8

Filing footnotes · ownership attribution and instrument terms

F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.

F2: This transaction was executed in multiple trades at prices ranging from $203.0000 to $203.1200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $202.0000 to $202.9600. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $201.0000 to $201.9900. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $200.0000 to $200.9950. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

GENERAL MILLS INC

Report date September 29, 2026 · Filed October 01, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	14,591.9026	Reported balance After 2026-09-29 transaction · row 1 1 source row Row 1 · 2026-09-29 · Grant · Acquired 5,323 · Balance 14,591.9026 F1: Automatic grant of restricted stock units under the General Mills, Inc. 2022 Stock Compensation Plan. Each restricted stock unit vests on the date of the next annual meeting of General Mills stockholders and represents a contingent right to receive one share of General Mills, Inc. common stock.
Common StockSEC Table I · non-derivative	Indirectby Trust	43	Reported balance Holding disclosure · report date 2026-09-29 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 43

Filing footnotes · ownership attribution and instrument terms

F1: Automatic grant of restricted stock units under the General Mills, Inc. 2022 Stock Compensation Plan. Each restricted stock unit vests on the date of the next annual meeting of General Mills stockholders and represents a contingent right to receive one share of General Mills, Inc. common stock.

Origin Materials, Inc.

Report date August 15, 2022 · Filed August 17, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	157,986	Reported balance After 2022-08-15 transaction · row 1 1 source row Row 1 · 2022-08-15 · Grant · Acquired 18,361 · Balance 157,986 F1: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest on the earlier of June 24, 2023 or the Issuer's next annual meeting of stockholders, provided that Reporting Person continues to provide services to the Company through such vesting date.
Common StockSEC Table I · non-derivative	IndirectBy Trust	15,000	Reported balance Holding disclosure · report date 2022-08-15 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 15,000 F2: Shares are held directly by The Benno Dorer Revocable Trust, of which the Reporting Person is Trustee.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest on the earlier of June 24, 2023 or the Issuer's next annual meeting of stockholders, provided that Reporting Person continues to provide services to the Company through such vesting date.

F2: Shares are held directly by The Benno Dorer Revocable Trust, of which the Reporting Person is Trustee.

V F CORP

Report date May 28, 2024 · Filed May 31, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	60,936.003	Reported balance After 2024-05-28 transaction · row 1 1 source row Row 1 · 2024-05-28 · Grant · Acquired 7,288 · Balance 60,936.003
FY 2025 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.35 · Expires 2034-05-27	Direct	18,256	Reported balance After 2024-05-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-05-28 · Grant · Acquired 18,256 · Balance 18,256
Commom StockSEC Table I · non-derivative	IndirectBy 2024 Living Trust	11,592	Reported balance Holding disclosure · report date 2024-05-28 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 11,592

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 02, 2020 Filed Mar 5, 2020 00:17 UTC	CLOROX CO /DE/ CLX · Entity 3474	SaleCommon Stock	4,201	$163.39	$686,413.57	Disclosure SEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 4 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,489 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F3 · price: This transaction was executed in multiple trades at prices ranging from $162.9550 to $163.9500. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
March 02, 2020 Filed Mar 5, 2020 00:17 UTC	CLOROX CO /DE/ CLX · Entity 3474	SaleCommon Stock	1,998	$164.53	$328,724.15	Disclosure SEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 3 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,690 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F2 · price: This transaction was executed in multiple trades at prices ranging from $164.0150 to $164.9100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
March 02, 2020 Filed Mar 5, 2020 00:17 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	50,780	$89.82	$4,561,059.60	Disclosure SEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
March 02, 2020 Filed Mar 5, 2020 00:17 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	221,170	$100.24	$22,170,080.80	Disclosure SEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
September 17, 2019 Filed Sep 19, 2019 23:34 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantStock Option (Right to Buy) · Derivative	147,367	$0.00 Strike: $155.54	$0.00	Disclosure SEC source: 0001225208-19-012716 · doc4.xml · derivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,367 Underlying: Common Stock · 147,367 shares Expires 2029-09-17 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
August 22, 2019 Filed Aug 26, 2019 21:57 UTC	CLOROX CO /DE/ CLX · Entity 3474	Tax withholdingCommon Stock	9,005	$159.15	$1,433,145.75	Disclosure SEC source: 0001225208-19-011886 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,344 Read SEC document
August 22, 2019 Filed Aug 26, 2019 21:57 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantCommon Stock	39,351	$159.15	$6,262,711.65	Disclosure SEC source: 0001225208-19-011886 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,349 F1 · kind: Settlement of 2016 Performance Unit Grant that vested 8/22/2019. Read SEC document
August 22, 2019 Filed Sep 9, 2019 22:28 UTC Amendment	CLOROX CO /DE/ CLX · Entity 3474	GrantCommon Stock	20,061	$159.15	$3,192,708.15	Disclosure SEC source: 0001225208-19-012271 · doc4a.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,059 F1 · kind: Settlement of 2016 Performance Unit Grant that vested 8/22/2019. F2 · shares: This filing amends the Form 4 filed on 8/26/19 to correct an inadvertent overstatement of the amount of settled performance units. Read SEC document
May 24, 2019 Filed May 29, 2019 17:48 UTC	V F CORP VFC · Entity 3887	GrantFY 2020 Non-qualified Stock Option (Right to Buy) · Derivative	4,613	$0.00 Strike: $84.37	$0.00	Disclosure SEC source: 0001127602-19-020105 · form4.xml · derivative · entry 2 Dorer Benno O · CIK 0001456667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,613 Underlying: Commom Stock · 4,613 shares Expires 2029-05-23 Read SEC document
May 24, 2019 Filed May 29, 2019 17:48 UTC	V F CORP VFC · Entity 3887	GrantCommon Stock	978	$0.00	$0.00	Disclosure SEC source: 0001127602-19-020105 · form4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,204.136 Read SEC document
May 24, 2019 Filed Jun 28, 2019 21:06 UTC Amendment	V F CORP VFC · Entity 3887	GrantFY 2020 Non-qualified Stock Option (Right to Buy) · Derivative	4,842	$0.00 Strike: $84.23	$0.00	Disclosure SEC source: 0001127602-19-023054 · form4a.xml · derivative · entry 2 Dorer Benno O · CIK 0001456667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,842 Underlying: Commom Stock · 4,842 shares Expires 2029-05-23 F2 · derivative.exercise_price: This amended Form 4 corrects (i) the number of stock options granted to the reporting person on May 24, 2019 from 4,613 to 4,842 and (ii) the exercise price of such stock options from $84.37 to $84.23. F2 · shares: This amended Form 4 corrects (i) the number of stock options granted to the reporting person on May 24, 2019 from 4,613 to 4,842 and (ii) the exercise price of such stock options from $84.37 to $84.23. Read SEC document
May 24, 2019 Filed Jun 28, 2019 21:06 UTC Amendment	V F CORP VFC · Entity 3887	GrantCommon Stock	980	$0.00	$0.00	Disclosure SEC source: 0001127602-19-023054 · form4a.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,206.136 F1 · shares: This amended Form 4 corrects the number of restricted stock units granted to the reporting person on May 24, 2019 from 978 to 980. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	40,798	$0.00 Strike: $84.45	$0.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · derivative · entry 17 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,798 shares Expires 2023-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	17,460	$0.00 Strike: $57.25	$0.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · derivative · entry 16 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,460 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	19,826	$0.00 Strike: $66.48	$0.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · derivative · entry 15 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,826 shares Expires 2020-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	19,809	$0.00 Strike: $68.15	$0.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · derivative · entry 14 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,809 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	31,058	$0.00 Strike: $72.11	$0.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · derivative · entry 13 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,058 shares Expires 2022-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	26,559	$0.00 Strike: $74.09	$0.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · derivative · entry 12 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,559 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	SaleCommon Stock	63,066	$164.86	$10,397,117.52	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 10 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,998 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F5 · price: This transaction was executed in multiple trades at prices ranging from $164.3350 to $165.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6 · balance_after: Includes 998 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	SaleCommon Stock	50,279	$164.01	$8,246,273.87	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 9 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,064 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F4 · price: This transaction was executed in multiple trades at prices ranging from $163.33 to $164.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	SaleCommon Stock	37,497	$165.83	$6,218,033.77	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 8 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,343 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F3 · price: This transaction was executed in multiple trades at prices ranging from $165.35 to $166.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	SaleCommon Stock	1,607	$166.38	$267,369.93	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 7 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,840 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F2 · price: This transaction was executed in multiple trades at prices ranging from $166.36 to $166.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	17,460	$57.25	$999,585.00	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 6 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	19,809	$68.15	$1,349,983.35	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 5 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	19,826	$66.48	$1,318,032.48	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 4 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	26,559	$74.09	$1,967,756.31	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 3 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	31,058	$72.11	$2,239,592.38	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
December 04, 2018 Filed Dec 7, 2018 01:13 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	40,798	$84.45	$3,445,391.10	Disclosure SEC source: 0001225208-18-016313 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document
September 18, 2018 Filed Sep 20, 2018 22:04 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantStock Option (Right to Buy) · Derivative	128,800	$0.00 Strike: $151.85	$0.00	Disclosure SEC source: 0001225208-18-013641 · doc4.xml · derivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,800 Underlying: Common Stock · 128,800 shares Expires 2028-09-18 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
August 16, 2018 Filed Aug 20, 2018 22:43 UTC	CLOROX CO /DE/ CLX · Entity 3474	Tax withholdingCommon Stock	14,496	$146.77	$2,127,577.92	Disclosure SEC source: 0001225208-18-012761 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,939 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document
August 16, 2018 Filed Aug 20, 2018 22:43 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantCommon Stock	29,235	$146.77	$4,290,820.95	Disclosure SEC source: 0001225208-18-012761 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,435 F1 · kind: Settlement of 2015 Performance Unit Grant that vested 8/16/2018. Read SEC document
February 21, 2018 Filed Feb 23, 2018 17:46 UTC	V F CORP VFC · Entity 3887	Grant2018 Non-qualified Stock Option (Right to Buy) · Derivative	5,404	$74.80 Strike: $74.80	$404,219.20	Disclosure SEC source: 0001127602-18-007960 · form4.xml · derivative · entry 2 Dorer Benno O · CIK 0001456667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Underlying: Commom Stock · 5,404 shares Expires 2028-02-20 Read SEC document
February 21, 2018 Filed Feb 23, 2018 17:46 UTC	V F CORP VFC · Entity 3887	GrantCommon Stock	1,655	$0.00	$0.00	Disclosure SEC source: 0001127602-18-007960 · form4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,186.35 Read SEC document
December 07, 2017 Filed Dec 8, 2017 21:40 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionStock Option (Right to Buy) · Derivative	14,380	$0.00 Strike: $63.95	$0.00	Disclosure SEC source: 0001225208-17-018399 · doc4.xml · derivative · entry 4 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,380 shares Expires 2018-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 07, 2017 Filed Dec 8, 2017 21:40 UTC	CLOROX CO /DE/ CLX · Entity 3474	Tax withholdingCommon Stock	9,541	$144.24	$1,376,193.84	Disclosure SEC source: 0001225208-17-018399 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,212 Read SEC document
December 07, 2017 Filed Dec 8, 2017 21:40 UTC	CLOROX CO /DE/ CLX · Entity 3474	Exercise / conversionCommon Stock	14,380	$63.95	$919,601.00	Disclosure SEC source: 0001225208-17-018399 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 07, 2017 Filed Dec 26, 2017 22:12 UTC Amendment	CLOROX CO /DE/ CLX · Entity 3474	Tax withholdingCommon Stock	10,553	$144.24	$1,522,164.72	Disclosure SEC source: 0001225208-17-019067 · doc4a.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,200 F1 · kind: This filing corrects the number of reported shares withheld in the Form 4 filed on 12/8/2017. Read SEC document
November 01, 2017 Filed Nov 9, 2017 00:31 UTC	CLOROX CO /DE/ CLX · Entity 3474	Tax withholdingCommon Stock	570	$128.02	$72,971.40	Disclosure SEC source: 0001225208-17-017109 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,373 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document
November 01, 2017 Filed Nov 9, 2017 00:31 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantCommon Stock	24,303	$128.02	$3,111,270.06	Disclosure SEC source: 0001225208-17-017109 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,943 F1 · kind: Settlement of November 2014 Performance Unit Grant that vested 11/01/2017, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document
September 12, 2017 Filed Sep 14, 2017 21:25 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantStock Option (Right to Buy) · Derivative	171,960	$0.00 Strike: $135.57	$0.00	Disclosure SEC source: 0001225208-17-015015 · doc4.xml · derivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,960 Underlying: Common Stock · 171,960 shares Expires 2027-09-12 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
August 17, 2017 Filed Aug 21, 2017 22:10 UTC	CLOROX CO /DE/ CLX · Entity 3474	Tax withholdingCommon Stock	203	$137.17	$27,845.51	Disclosure SEC source: 0001225208-17-014216 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,640 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document
August 17, 2017 Filed Aug 21, 2017 22:10 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantCommon Stock	8,699	$137.17	$1,193,241.83	Disclosure SEC source: 0001225208-17-014216 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,843 F1 · kind: Settlement of 2014 Performance Unit Grant that vested 8/17/2017, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document
March 08, 2017 Filed Mar 10, 2017 23:01 UTC	CLOROX CO /DE/ CLX · Entity 3474	PurchaseCommon Stock	4	$136.39	$545.56	Disclosure SEC source: 0001225208-17-006104 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · As UTMA custodian for son Disclosed balance after: 8 F1 · ownership.nature: Shares are held by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. Read SEC document
March 08, 2017 Filed Mar 10, 2017 23:01 UTC	CLOROX CO /DE/ CLX · Entity 3474	PurchaseCommon Stock	4	$136.40	$545.61	Disclosure SEC source: 0001225208-17-006104 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · As UTMA custodian for son Disclosed balance after: 4 F1 · ownership.nature: Shares are held by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. Read SEC document
September 13, 2016 Filed Sep 15, 2016 20:54 UTC	CLOROX CO /DE/ CLX · Entity 3474	GrantStock Option (Right to Buy) · Derivative	172,850	$0.00 Strike: $123.09	$0.00	Disclosure SEC source: 0001225208-16-039396 · doc4.xml · derivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,850 Underlying: Common Stock · 172,850 shares Expires 2026-09-13 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.